Spectrum Pharmaceuticals buy krebskrebs
Start price
23.08.21
/
50%
€2.01
Target price
23.08.22
€3.00
Performance (%)
-34.26%
End price
24.08.22
€1.32
Summary
This prediction ended on 24.08.22 with a price of €1.32. Massive losses of -34.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Spectrum Pharmaceuticals | - | - | - |
iShares Core DAX® | 3.178% | 0.980% | 15.331% |
iShares Nasdaq 100 | 2.972% | 0.925% | 39.831% |
iShares Nikkei 225® | 0.545% | -4.556% | 17.661% |
iShares S&P 500 | 2.367% | 0.833% | 30.000% |
Comments by krebskrebs for this prediction
In the thread Spectrum Pharmaceuticals diskutieren
Buy mit Kursziel 3,0
In the thread Trading Spectrum Pharmaceuticals
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten